Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin

Journal of Clinical Pharmacy and Therapeutics

Volumn 33, Issue 4, 2008, Pages 409-417

  Halacova, M ^a   Kotaska, K ^a   Kukacka J , ^a   Vavrova, V ^a   Kuzelova, M ^b   Ticha J , ^c   Prusa, R ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Faculty of Natural Sciences   (Slovakia)

^c NA HOMOLCE HOSPITAL   (Czech Republic)

Author keywords

Amikacin clearance; Creatinine; Cystatin C; Cystic fibrosis; Glomerular filtration rate

Indexed keywords

AMIKACIN; CREATININE; CYSTATIN C; N ACETYL BETA GLUCOSAMINIDASE; ACETYLGLUCOSAMINIDASE; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CYSTATIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; CYSTIC FIBROSIS; DRUG CLEARANCE; DRUG MEGADOSE; FEMALE; FLUORESCENCE POLARIZATION; FLUOROMETRY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; KIDNEY TUBULE FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; TURBIDIMETRY; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG MONITORING; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; PATHOLOGY; PRESCHOOL CHILD; ROC CURVE; TIME; URINE;

ACETYLGLUCOSAMINIDASE; ADOLESCENT; ADULT; AMIKACIN; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CREATININE; CYSTATINS; CYSTIC FIBROSIS; DRUG MONITORING; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; MALE; ROC CURVE; TIME FACTORS;

EID: 49849104380     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00932.x     Document Type: Article

References (33)

1. Linblad HG, Berg UB (1994) Comparative evaluation of iohexol and inulin clearance for glomerular filtration rate determinations. Acta Paediatrica, 83, 418-422.
2. Swan SK (1997) The search continues: an ideal marker of glomerular filtration rate. Clinical Chemistry, 43, 913-914.
3. Gral T, Young M (1980) Measured versus estimated creatinine clearance in the elderly as an index of renal function. Journal of American Geriatrics Society, 28, 492-496.
4. Mann HJ, Canafax DM, Cipolle RJ et al. (1985) Increased dosage requirements of tobramycin and gentamicin for treating Pseudomonas pneumonia in patients with cystic fibrosis. Pediatric Pulmonology, 1, 238-243.
5. Levy J, Smith AL, Koup JR et al. (1984) Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study. Journal of Pediatrics, 105, 117-124.
6. Rey E, Treluyer JM, Pons G (1998) Drug disposition in cystic fibrosis. Clinical Pharmacokinetics, 35, 313-340.
7. Deinum J, Derkx FHM (2000) Cystatin C for estimation of glomerular filtration rate? Lancet, 356, 1624.
8. Barrett AJ, Davies ME, Grubb A (1984) The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochemical and Biophysical Research Communications, 120, 631-636.
9. Newman DJ, Thakkar H, Edwards RG et al. (1995) Serum cystatin C measured by automated immunoassay. A more sensitive marker of changesin GFR than serum creatinine. Kidney International, 47, 312-318.
10. Kyhse-Andersen J, Schmidt C, Nordin G et al. (1994) Serum cystatin C, determined by rapid, automated, particle enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clinical Chemistry, 40, 1921-1926.
11. Keevil BG, Kilpatric ES, Nichols SP et al. (1998) Biological variation of cystatin C. Implications for the assessment of glomerular filtration rate. Clinical Chemistry, 44, 1535-1539.
12. Prusa R (2000) Orientační rozmezí hodnot laboratorních vyšetření podle věkových skupin. Praha: Fakultní nemocnice v Motole.
13. Pocsi I, Taylor SA, Richardson AC et al. (1990) ''VRA-GlcNAc'': novel substrate for N-acetylglucosaminidase applied to assay of this enzyme in urine. Clinical Chemistry, 36, 1884-1888.
14. Blirup-Jensen S (2001) Protein standardization III: method optimisation. Basic principles for quantitative determination of human serum proteins on automated instruments based on turbidimetry or nephelometry. Clinical Chemistry and Laboratory Medicine, 39, 1098-1109.
15. Tabata M, Kidneyo T, Totani M et al. (1983) Automated assay of creatinine in serum as simplified by the use of immobilised enzymes, creatinine deaminase and glutamate dehydrogenase. Analytical Biochemistry, 134, 44-49.
16. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31-34.
17. Schwartz GJ, Haycock GB, Edelmann CM Jr et al. (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics, 58, 259-263.
18. Grubb A, Nyman U, Bjo″rk J et al. (2005) Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clinical Chemistry, 51, 1420-1431.
19. Larsson A,MalmJ, GrubbAet al. (2004) Calculation of glomerular filtration rate expressed in mL/ min from plasma cystatin C values in mg/ l. Scandinavian Journal of Clinical and Laboratory Investigation, 64, 25-30.
20. MW/PHARM [Computer Program] (1999) User manual, version 3.30. Groningen: University Center of Pharmacy.
21. Nix DE, Thomas JK, Symonds WT et al. (1997) Assessment of the enzymuria resulting from genramicin alone and combinations of gentamicin with various beta-lactam antibiotics. Annals of Pharmacotherapy, 31, 696-703.
22. Marchewka Z, Dlugosz A (1998) Enzymes in urine as markers of nephrotoxicity of cytostatic agents and aminoglycoside antibiotics. International Urology and Nephrology, 30, 339-348.
23. Ellis D, Fried WA, Yunis EJ et al. (1981) Acute interstitial nephritis in children. A report of 13 cases and review of the literature. Pediatrics, 67, 862-870.
24. Ring E, Eber E, Erwa W et al. (1998) Urinary N-acetyl- beta-D-glucosaminidase acitivity in patients with cystic fibrosis on long term gentamicin inhalation. Archives of Disease in Childhood, 78, 540-543.
25. Horber FF, Scheidegger J, Frey FJ (1985) Overestimation of renal function in glucocorticosteroid treated patients. European Journal of Clinical Pharmacology, 28, 537-541. (Pubitemid 15030779)
26. Cocchetto DM, Tschanz C, Bjornsson TD (1983) Decreased rate of creatinine production in patients with hepatic disease: implications for estimation of creatinine clearance. Therapeutic Drug Monitoring, 5, 161-168.
27. Hermida J, Tutor JC (2006) Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin and vancomycin. Therapeutic Drug Monitoring, 28, 326-331.
28. Schemesh O, Golberty H, Kriss JP et al. (1985) Limitations of creatinine clearance as a filtration marker of glomerulopathic patients. Kidney International, 28, 830-838.
29. Bjornsson TD (1979) Use of serum creatinine concentrations to determine renal function. Clinical Pharmacokinetics, 4, 200-222.
30. Schück O, Teplan J, Sibová J et al. (2004) Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockroft and Gault formula with regard to drug dosage adjustment. International Journal Clinical Pharmacology Therapy, 42, 93-97.
31. O'Riordan S, Ouldred E, Brice SHDJ et al. (2002) Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine. British Journal of Clinical Pharmacology, 53, 398-402.
32. Hallberg P, Melhus H, Hanson LO (2004) Cystatin C vs creatinine as markers of renal function in patients on digoxin treatment. Upsala Journal of Medical Sciences, 109, 247-253.
33. Hoppe A, Séronie-Vivien AN, Thomas F et al. (2005) Serum cystatin C is a better marker of topotecan clearance than serum creatinine. Clinical Cancer Research, 11, 3038-3044.